Malignant Melanoma Completed Phase 2 Trials for CT-011 (DB05916)

Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0029825 (Malignant Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01435369Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic MelanomaTreatment